Bovine papillomavirus

Lore & Background

Six types of BPV have been characterized—BPV-1 to BPV-6—divided into three subgroups. Deltapapillomavirus (types 1 and 2) cause fibropapillomas involving both epithelium and dermis, with BPV-1 infecting paragenital areas and BPV-2 infecting skin, alimentary canal, and urinary bladder. Xipapillomavirus (types 3, 4, and 6) lack the E6 oncoprotein and cause pure papillomas of epithelium only, with BPV-3 infecting skin, BPV-4 the upper alimentary tract, and BPV-6 teats and udders. Epsilonpapillomavirus (BPV-5) has intermediate features and infects teats and udders.

Reader's Guide

Bovine papillomaviruses are significant as a natural model for understanding papillomavirus infection and carcinogenesis. They are highly prevalent in cattle, with about 50% of UK cattle estimated to bear lesions. BPV-4 causes squamous cell carcinomas of the alimentary tract, and BPV-1/2 causes urinary bladder cancers, both in animals that have fed on bracken, which contains immunosuppressants and mutagens. These bracken-associated tumours may model some human oesophageal cancers. BPV-1 and BPV-2 also cause equine sarcoid in horses and donkeys, the only known natural cross-species papillomavirus infection. Vaccine systems developed against BPV—using virus-like particles assembled from L1 protein—served as models for the successful prophylactic human papillomavirus vaccines Gardasil and Cervarix. Therapeutic vaccines based on E7 and L2 have also been developed in cattle.

Did You Know?

• BPVs are a paraphyletic group of DNA viruses common in cattle.
• BPV-1 and BPV-2 cause equine sarcoid, the only known natural cross-species papillomavirus infection.
• Xipapillomavirus group BPVs lack the E6 oncoprotein.
• Vaccines against BPV types 1, 2, and 4 were developed by M. Saveria Campo and others.

Viral Architecture and Genetic Blueprint

Bovine papillomaviruses present as compact, non-enveloped particles whose icosahedral capsid measures roughly fifty to sixty nanometres across. Two structural proteins, L1 and L2, assemble this shell, with the C-terminal end of L1 projecting outward. Enclosed within is a circular, double-stranded DNA genome spanning between 7.3 and 8.0 kilobases. All open reading frames reside on a single strand and are partitioned into an early region and a late region. The early segment encodes the nonstructural proteins E1 through E7, among which E5, E6, and E7 function as oncoproteins; notably, members of the Xipapillomavirus subgroup have lost E6 entirely. The late region produces the capsid proteins L1 and L2. A non-coding long control region also occupies the genome. This conserved layout, shared broadly with other papillomaviruses, has made BPVs a valuable experimental system for dissecting how papillomavirus molecular biology drives cellular transformation and, ultimately, malignancy.

Taxonomic Diversity and Tissue Tropism

Six characterised BPV types—numbered one through six—fall into three broad subgroups that differ in genome size, protein repertoire, and the tissues they target. The Deltapapillomavirus group (types 1 and 2) carries a genome near 7.9 kb and is unique among papillomaviruses in driving proliferation of both keratinocytes and the underlying fibroblasts, producing benign fibropapillomas that extend into the dermis. Type 1 localises to paragenital sites such as the penis, teats, and udders, while type 2 affects the skin, alimentary canal, and urinary bladder. The Xipapillomavirus group (types 3, 4, and 6) has a smaller genome of roughly 7.3 kb, lacks the E6 oncoprotein, and produces pure epithelial papillomas. Type 3 targets the skin, type 4 the upper alimentary tract, and type 6 the teats and udders. Epsilonpapillomavirus, represented solely by type 5, occupies an intermediate position, infecting teats and udders and capable of causing both papillomas and fibropapillomas. Thirteen additional putative types have since been identified but remain unassigned to subgroups.

Clinical Presentation, Prevalence, and Spread

Bovine papillomavirus infection is remarkably widespread; in the United Kingdom, approximately half of all cattle are estimated to carry visible lesions at some point. Cutaneous warts appear most frequently in animals younger than two years and typically regress on their own as the immune system matures, leaving little scarring. The duration of a single episode ranges from a single month to well over a year, and recurrence is not uncommon. Warts produced by the Xipapillomavirus group take on a cauliflower-like morphology and can grow to the size of a clenched fist, favouring the head, neck, and shoulders. Deltapapillomavirus fibropapillomas, by contrast, present as nodular growths. While most skin lesions are largely cosmetic, large warts can bleed and invite secondary infection, teat warts may trigger mastitis and disrupt suckling or milking, and genital fibropapillomas can cause pain and compromise reproductive function. In chronically immunosuppressed cattle, extensive papillomatosis of the upper gastrointestinal tract can impair both eating and breathing. Transmission occurs readily through shared objects such as fence posts and halters, from the teats of lactating cows to calves via minor abrasions, and through contaminated tattooing or tagging equipment. Warts harbour large quantities of relatively stable infectious virus, making environmental spread a persistent challenge.

Cancer Co-factors, Cross-Species Effects, and Research Legacy

The most serious consequence of BPV infection is its role as a cancer co-factor, but only in the context of bracken consumption. BPV-4 is linked to squamous cell carcinomas of the alimentary tract, while BPV-1 and BPV-2 are associated with carcinomas and haemangioendotheliomas of the urinary bladder. Bracken contains immunosuppressants and mutagens such as quercetin and ptaquiloside; chronic low-level ingestion acts as a co-carcinogen alongside the virus. Tumour development is multistep, involving activation of Ras, mutation or downregulation of the p53 tumour suppressor in alimentary tract cancers, and alteration of the FHIT gene in bladder tumours. Strikingly, no viral particles are produced within these neoplasms. Because bracken is consumed as food or herbal remedy in parts of South America, China, Japan, and Korea, and HPV DNA appears in roughly eighteen percent of human oesophageal squamous cell carcinomas, these bovine tumours may model aspects of human oesophageal cancer. Beyond cattle, BPV-1 and BPV-2 can induce sarcomas in equids (equine sarcoid) and, experimentally, in rabbits, hamsters, and mice, though the virus does not integrate into the host genome in these cross-species infections.